Home
About
FAQ
History (7)
Norton, Michael
Retrograde activation of CB1R by muscarinic receptors protects against central organophosphorus toxicity.
Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins.
Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future.
Model Informed Drug Development: Novel Oncology Agents are Lost in Translation.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Model Informed Drug Development: Novel Oncology Agents are Lost in Translation.
Mayawala K, de Alwis DP, Sachs JR. Model Informed Drug Development: Novel Oncology Agents are Lost in Translation. Clin Cancer Res. 2019 11 15; 25(22):6564-6566.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Medical Oncology
Treatment Outcome
authors with profiles
Jeffrey R. Sachs MD